RxDoctor Payments DataLook up a doctor →

Quito Carr

Family Medicine · Albuquerque, NMNPI 1235147968

Payments from drug & device makers

$10,363,919in general payments, 2019–2025

Across 598 payments — averaging $17,331 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Modernatx, Inc.$4.9M
  • AstraZeneca$2.7M
  • Janssen Research & Development, LLC$873K
  • Pfizer$842K
  • GSK$450K
  • Johnson & Johnson$367K
  • plus $233K from 3 others
$453in research payments, 2019–2025

Across 2 payments — averaging $226.58 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$453

What the payments were for

  • Travel & lodging$1,98968%
  • Food & beverage$91532%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Modernatx, Inc.212$4,901,999
AstraZeneca10$2,697,135
Janssen Research & Development, LLC49$872,852
Pfizer121$841,816
GSK127$449,918
Johnson & Johnson35$367,348
Seqirus USA Inc21$175,961
Sanofi Pasteur Inc.20$35,967
Eli Lilly3$20,922

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,363,919 in reported general payments places this provider in the 95th percentile of 717 family medicine providers in New Mexico.

See all family medicine providers in New Mexico

Other family medicine in Albuquerque

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →